Galena Biopharma (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Rising rates of cancer are going to come at a major cost, and it's looking more and more like the solution is going to have ...

Key Insights Solaris Resources' significant insider ownership suggests inherent interests in company's expansion ...

No speed limits, no traffic—just a runway, a screaming V8, and the SLS AMG doing what it was built to do.

Find out if Solaris Resources Inc Ordinary Shares (SLS:XTSE) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value ...

CONTINUED... Read this and more news for Oncolytics Biotech at: In other recent industry developments and happenings in the m ...

With gold prices running hot, explorers should add a second string to their bow. Magmatic is doing just that, writes Barry ...

Nothing is so permanent as a temporary government program,” Milton Friedman observed decades ago. Such applies to two current ...

Enzo Maresca's side are poised to step up negotiations for an electric 20-year-old forward as they try to build on the Liam ...

Peter Andre has subtly responded to the renewed attention around his past relationship with Katie Price, following her unexpected remarks.